CompanyDrug

Clinical Research on rAAV Gene Drug ZS805 for Fabry Disease Launched by Zhishan Weixin

CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ Subsidiary Shengdi Pharmaceuticals Receives NMPA Approval for HRS-9057

CompanyDrug

Beijing Aosaikang’s Combo Therapy for NSCLC Accepted for Clinical Trial by NMPA

Company

Lundbeck A/S Reports 7% YOY Revenue Increase in Q3 2023 and 9% Growth for the First Three Quarters

Company

Sandoz Invests in New Biosimilars and Penicillin API Production Sites in Europe

Company

Merck Reports Q3 2023 Financial Results with Mixed Performance Across Segments

CompanyDeals

AimingMed Partners with Becton, Dickinson and Co. to Advance Tumor Precision Medicine

CompanyDrug

China’s NMPA Grants Conditional Approval for Juventas’ CAR-T Therapy Inaticabtagene Autoleucel

Policy / Regulatory

China’s NMPA Officially Seeks Membership in the Pharmaceutical Inspection Co-operation Scheme (PIC/S)

CompanyDrug

Eli Lilly’s Zepbound Approved by FDA for Chronic Weight Management in Adults

Company

BeiGene Ltd Reports Q3 2023 Financial Results with 102% YOY Revenue Increase

CompanyDeals

Danaher Corporation Partners with CHEA to Boost Oncology Centers in Chinese Counties